SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) is pleased to offer a highly anticipated series of eight, online seminars to address key questions in the field of cancer immunotherapy, both in-depth and in an easily accessible format.

The third seminar in the series, IL-2 Variants and IL-15: A Deep Dive in Cancer Immunotherapy Targets, was held July 19, 2021 from 4:30 - 6:30 p.m. ET.

Moderators:

• Rafi Ahmed, PhD – Emory University
• Michael B. Atkins, MD – Georgetown Lombardi Comprehensive Cancer Center
• Warren J. Leonard, MD – Laboratory of Molecular Immunology, NHLBI

Indicates this content is not available on-demand. 


Presenters:
Michael B. Atkins, MD – Georgetown Lombardi Comprehensive Cancer Center, "IL-2 Clinical Development: Lessons Learned, but Possibly Forgotten"

Warren J. Leonard, MD – Laboratory of Molecular Immunology, NHLBI, "Fine-tuning IL-2 Signaling to Enhance Translational Potential"

Jamie B. Spangler, PhD – Johns Hopkins University, "Engineering Designer Cytokines for Immunotherapy"

Thomas A. Waldmann, MD – National Cancer Institute, National Institutes of Health, "IL-15 the Conductor of the Immunological Orchestra"


Targets for Cancer Immunotherapy: A Deep Dive Seminar Series is supported, in part, by grants from Alkermes, Inc., Genentech, a member of the Roche Group, Incyte Corporation, and Merck & Co., Inc. (as of 5/18/2021).